Radiopharm Theranostics Ltd
RADX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001949257
No open-market purchases or sales by Radiopharm Theranostics Ltd insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $1.18M in total; no superinvestor holds it.
Other share classesRDPTF
Q2 2025 vs. Q1 2025
How the institutions holding Radiopharm Theranostics Ltd changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 3 | 5 | +2 |
| Shares | 342.9K | 339.7K | −3.23K (−0.9%) |
| Value | $1.65M | $1.58M | −$72.5K (−4.4%) |
New holders (2)
Institutions that held Radiopharm Theranostics Ltd at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Group AG | 17,740 | $82.3K | 0.00% |
| The PNC Financial Services Group, Inc. | 8,000 | $37.1K | 0.00% |
Sold out (0)
Institutions that held Radiopharm Theranostics Ltd at the end of Q1 2025 and filed for Q2 2025 without it.
None.